| Name | Enokizumab |
|---|
| Description | Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways[1]. |
|---|---|
| Related Catalog | |
| Target |
IL-9[1] |
| No Any Chemical & Physical Properties |